Cathie Wood acquired 3.7M Apogee Therapeutics shares worth $336M. That's 2.24% of their equity portfolio (15th largest holding). The investor owns 6.61% of the outstanding Apogee Therapeutics stock. The stake costed the investor $237M, netting the investor a gain of 42% so far.